Pharma & Healthcare
Global Pulmonary Embolism Therapeutics Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4145
- Pages: 95
- Figures: 115
- Views: 24
Lifestyle associated factors such as smoking, overweight, old-age pregnancy, and excessive use of estrogen supplements are some of the major causes of pulmonary embolism.
Market Analysis and Insights: Global Pulmonary Embolism Therapeutics Market
The global Pulmonary Embolism Therapeutics market is projected to grow from US$ 2548 million in 2024 to US$ 4273.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Pulmonary Embolism Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pulmonary Embolism Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pulmonary Embolism Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pulmonary Embolism Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pulmonary Embolism Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pulmonary Embolism Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Boehringer Ingelheim International
Bristol-Myers Squibb
Daiichi Sankyo
F. Hoffmann-La Roche
Johnson & Johnson
Segment by Type
Oral
Parenteral
Segment by Application
Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pulmonary Embolism Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pulmonary Embolism Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pulmonary Embolism Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Pulmonary Embolism Therapeutics Market
The global Pulmonary Embolism Therapeutics market is projected to grow from US$ 2548 million in 2024 to US$ 4273.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Pulmonary Embolism Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pulmonary Embolism Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pulmonary Embolism Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pulmonary Embolism Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pulmonary Embolism Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pulmonary Embolism Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Boehringer Ingelheim International
Bristol-Myers Squibb
Daiichi Sankyo
F. Hoffmann-La Roche
Johnson & Johnson
Segment by Type
Oral
Parenteral
Segment by Application
Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pulmonary Embolism Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pulmonary Embolism Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pulmonary Embolism Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Child
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pulmonary Embolism Therapeutics Market Perspective (2019-2030)
2.2 Global Pulmonary Embolism Therapeutics Growth Trends by Region
2.2.1 Pulmonary Embolism Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pulmonary Embolism Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Pulmonary Embolism Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Pulmonary Embolism Therapeutics Market Dynamics
2.3.1 Pulmonary Embolism Therapeutics Industry Trends
2.3.2 Pulmonary Embolism Therapeutics Market Drivers
2.3.3 Pulmonary Embolism Therapeutics Market Challenges
2.3.4 Pulmonary Embolism Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pulmonary Embolism Therapeutics by Players
3.1.1 Global Pulmonary Embolism Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Pulmonary Embolism Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Pulmonary Embolism Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pulmonary Embolism Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Pulmonary Embolism Therapeutics Market Concentration Ratio
3.4.1 Global Pulmonary Embolism Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Embolism Therapeutics Revenue in 2023
3.5 Global Key Players of Pulmonary Embolism Therapeutics Head office and Area Served
3.6 Global Key Players of Pulmonary Embolism Therapeutics, Product and Application
3.7 Global Key Players of Pulmonary Embolism Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pulmonary Embolism Therapeutics Breakdown Data by Type
4.1 Global Pulmonary Embolism Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Pulmonary Embolism Therapeutics Forecasted Market Size by Type (2025-2030)
5 Pulmonary Embolism Therapeutics Breakdown Data by Application
5.1 Global Pulmonary Embolism Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Pulmonary Embolism Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pulmonary Embolism Therapeutics Market Size (2019-2030)
6.2 North America Pulmonary Embolism Therapeutics Market Size by Type
6.2.1 North America Pulmonary Embolism Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Pulmonary Embolism Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
6.3 North America Pulmonary Embolism Therapeutics Market Size by Application
6.3.1 North America Pulmonary Embolism Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Pulmonary Embolism Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
6.4 North America Pulmonary Embolism Therapeutics Market Size by Country
6.4.1 North America Pulmonary Embolism Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Pulmonary Embolism Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Pulmonary Embolism Therapeutics Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Pulmonary Embolism Therapeutics Market Size (2019-2030)
7.2 Europe Pulmonary Embolism Therapeutics Market Size by Type
7.2.1 Europe Pulmonary Embolism Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Pulmonary Embolism Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
7.3 Europe Pulmonary Embolism Therapeutics Market Size by Application
7.3.1 Europe Pulmonary Embolism Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Pulmonary Embolism Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
7.4 Europe Pulmonary Embolism Therapeutics Market Size by Country
7.4.1 Europe Pulmonary Embolism Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Pulmonary Embolism Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Pulmonary Embolism Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pulmonary Embolism Therapeutics Market Size (2019-2030)
8.2 China Pulmonary Embolism Therapeutics Market Size by Type
8.2.1 China Pulmonary Embolism Therapeutics Market Size by Type (2019-2024)
8.2.2 China Pulmonary Embolism Therapeutics Market Size by Type (2025-2030)
8.2.3 China Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
8.3 China Pulmonary Embolism Therapeutics Market Size by Application
8.3.1 China Pulmonary Embolism Therapeutics Market Size by Application (2019-2024)
8.3.2 China Pulmonary Embolism Therapeutics Market Size by Application (2025-2030)
8.3.3 China Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pulmonary Embolism Therapeutics Market Size (2019-2030)
9.2 Asia Pulmonary Embolism Therapeutics Market Size by Type
9.2.1 Asia Pulmonary Embolism Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Pulmonary Embolism Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
9.3 Asia Pulmonary Embolism Therapeutics Market Size by Application
9.3.1 Asia Pulmonary Embolism Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Pulmonary Embolism Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
9.4 Asia Pulmonary Embolism Therapeutics Market Size by Region
9.4.1 Asia Pulmonary Embolism Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Pulmonary Embolism Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Pulmonary Embolism Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Boehringer Ingelheim International
11.1.1 Boehringer Ingelheim International Company Details
11.1.2 Boehringer Ingelheim International Business Overview
11.1.3 Boehringer Ingelheim International Pulmonary Embolism Therapeutics Introduction
11.1.4 Boehringer Ingelheim International Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.1.5 Boehringer Ingelheim International Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Pulmonary Embolism Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Details
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Pulmonary Embolism Therapeutics Introduction
11.3.4 Daiichi Sankyo Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.3.5 Daiichi Sankyo Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Pulmonary Embolism Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.5.5 Johnson & Johnson Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Child
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pulmonary Embolism Therapeutics Market Perspective (2019-2030)
2.2 Global Pulmonary Embolism Therapeutics Growth Trends by Region
2.2.1 Pulmonary Embolism Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pulmonary Embolism Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Pulmonary Embolism Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Pulmonary Embolism Therapeutics Market Dynamics
2.3.1 Pulmonary Embolism Therapeutics Industry Trends
2.3.2 Pulmonary Embolism Therapeutics Market Drivers
2.3.3 Pulmonary Embolism Therapeutics Market Challenges
2.3.4 Pulmonary Embolism Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pulmonary Embolism Therapeutics by Players
3.1.1 Global Pulmonary Embolism Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Pulmonary Embolism Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Pulmonary Embolism Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pulmonary Embolism Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Pulmonary Embolism Therapeutics Market Concentration Ratio
3.4.1 Global Pulmonary Embolism Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Embolism Therapeutics Revenue in 2023
3.5 Global Key Players of Pulmonary Embolism Therapeutics Head office and Area Served
3.6 Global Key Players of Pulmonary Embolism Therapeutics, Product and Application
3.7 Global Key Players of Pulmonary Embolism Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pulmonary Embolism Therapeutics Breakdown Data by Type
4.1 Global Pulmonary Embolism Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Pulmonary Embolism Therapeutics Forecasted Market Size by Type (2025-2030)
5 Pulmonary Embolism Therapeutics Breakdown Data by Application
5.1 Global Pulmonary Embolism Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Pulmonary Embolism Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pulmonary Embolism Therapeutics Market Size (2019-2030)
6.2 North America Pulmonary Embolism Therapeutics Market Size by Type
6.2.1 North America Pulmonary Embolism Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Pulmonary Embolism Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
6.3 North America Pulmonary Embolism Therapeutics Market Size by Application
6.3.1 North America Pulmonary Embolism Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Pulmonary Embolism Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
6.4 North America Pulmonary Embolism Therapeutics Market Size by Country
6.4.1 North America Pulmonary Embolism Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Pulmonary Embolism Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Pulmonary Embolism Therapeutics Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Pulmonary Embolism Therapeutics Market Size (2019-2030)
7.2 Europe Pulmonary Embolism Therapeutics Market Size by Type
7.2.1 Europe Pulmonary Embolism Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Pulmonary Embolism Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
7.3 Europe Pulmonary Embolism Therapeutics Market Size by Application
7.3.1 Europe Pulmonary Embolism Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Pulmonary Embolism Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
7.4 Europe Pulmonary Embolism Therapeutics Market Size by Country
7.4.1 Europe Pulmonary Embolism Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Pulmonary Embolism Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Pulmonary Embolism Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pulmonary Embolism Therapeutics Market Size (2019-2030)
8.2 China Pulmonary Embolism Therapeutics Market Size by Type
8.2.1 China Pulmonary Embolism Therapeutics Market Size by Type (2019-2024)
8.2.2 China Pulmonary Embolism Therapeutics Market Size by Type (2025-2030)
8.2.3 China Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
8.3 China Pulmonary Embolism Therapeutics Market Size by Application
8.3.1 China Pulmonary Embolism Therapeutics Market Size by Application (2019-2024)
8.3.2 China Pulmonary Embolism Therapeutics Market Size by Application (2025-2030)
8.3.3 China Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pulmonary Embolism Therapeutics Market Size (2019-2030)
9.2 Asia Pulmonary Embolism Therapeutics Market Size by Type
9.2.1 Asia Pulmonary Embolism Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Pulmonary Embolism Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
9.3 Asia Pulmonary Embolism Therapeutics Market Size by Application
9.3.1 Asia Pulmonary Embolism Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Pulmonary Embolism Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
9.4 Asia Pulmonary Embolism Therapeutics Market Size by Region
9.4.1 Asia Pulmonary Embolism Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Pulmonary Embolism Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Pulmonary Embolism Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Boehringer Ingelheim International
11.1.1 Boehringer Ingelheim International Company Details
11.1.2 Boehringer Ingelheim International Business Overview
11.1.3 Boehringer Ingelheim International Pulmonary Embolism Therapeutics Introduction
11.1.4 Boehringer Ingelheim International Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.1.5 Boehringer Ingelheim International Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Pulmonary Embolism Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Details
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Pulmonary Embolism Therapeutics Introduction
11.3.4 Daiichi Sankyo Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.3.5 Daiichi Sankyo Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Pulmonary Embolism Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.5.5 Johnson & Johnson Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral
Table 4. Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Pulmonary Embolism Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pulmonary Embolism Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Pulmonary Embolism Therapeutics Market Share by Region (2019-2024)
Table 8. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Pulmonary Embolism Therapeutics Market Share by Region (2025-2030)
Table 10. Pulmonary Embolism Therapeutics Market Trends
Table 11. Pulmonary Embolism Therapeutics Market Drivers
Table 12. Pulmonary Embolism Therapeutics Market Challenges
Table 13. Pulmonary Embolism Therapeutics Market Restraints
Table 14. Global Pulmonary Embolism Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Pulmonary Embolism Therapeutics Revenue Share by Players (2019-2024)
Table 16. Global Top Pulmonary Embolism Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Embolism Therapeutics as of 2023)
Table 17. Global Pulmonary Embolism Therapeutics Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Pulmonary Embolism Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Pulmonary Embolism Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Pulmonary Embolism Therapeutics, Product and Application
Table 21. Global Key Players of Pulmonary Embolism Therapeutics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Pulmonary Embolism Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Pulmonary Embolism Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Pulmonary Embolism Therapeutics Revenue Share by Application (2019-2024)
Table 29. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Pulmonary Embolism Therapeutics Revenue Share by Application (2025-2030)
Table 31. North America Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Pulmonary Embolism Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Pulmonary Embolism Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Pulmonary Embolism Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Pulmonary Embolism Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Pulmonary Embolism Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Pulmonary Embolism Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Pulmonary Embolism Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Pulmonary Embolism Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Pulmonary Embolism Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Pulmonary Embolism Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Pulmonary Embolism Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Pulmonary Embolism Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Pulmonary Embolism Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Pulmonary Embolism Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Pulmonary Embolism Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Pulmonary Embolism Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Pulmonary Embolism Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 63. Boehringer Ingelheim International Company Details
Table 64. Boehringer Ingelheim International Business Overview
Table 65. Boehringer Ingelheim International Pulmonary Embolism Therapeutics Product
Table 66. Boehringer Ingelheim International Revenue in Pulmonary Embolism Therapeutics Business (2019-2024) & (US$ Million)
Table 67. Boehringer Ingelheim International Recent Developments
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Pulmonary Embolism Therapeutics Product
Table 71. Bristol-Myers Squibb Revenue in Pulmonary Embolism Therapeutics Business (2019-2024) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Developments
Table 73. Daiichi Sankyo Company Details
Table 74. Daiichi Sankyo Business Overview
Table 75. Daiichi Sankyo Pulmonary Embolism Therapeutics Product
Table 76. Daiichi Sankyo Revenue in Pulmonary Embolism Therapeutics Business (2019-2024) & (US$ Million)
Table 77. Daiichi Sankyo Recent Developments
Table 78. F. Hoffmann-La Roche Company Details
Table 79. F. Hoffmann-La Roche Business Overview
Table 80. F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Product
Table 81. F. Hoffmann-La Roche Revenue in Pulmonary Embolism Therapeutics Business (2019-2024) & (US$ Million)
Table 82. F. Hoffmann-La Roche Recent Developments
Table 83. Johnson & Johnson Company Details
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Pulmonary Embolism Therapeutics Product
Table 86. Johnson & Johnson Revenue in Pulmonary Embolism Therapeutics Business (2019-2024) & (US$ Million)
Table 87. Johnson & Johnson Recent Developments
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Pulmonary Embolism Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. Parenteral Features
Figure 5. Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Pulmonary Embolism Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. Adult Case Studies
Figure 8. Child Case Studies
Figure 9. Pulmonary Embolism Therapeutics Report Years Considered
Figure 10. Global Pulmonary Embolism Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Pulmonary Embolism Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pulmonary Embolism Therapeutics Market Share by Region: 2023 VS 2030
Figure 13. Global Pulmonary Embolism Therapeutics Market Share by Players in 2023
Figure 14. Global Top Pulmonary Embolism Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Embolism Therapeutics as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Pulmonary Embolism Therapeutics Revenue in 2023
Figure 16. North America Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
Figure 18. North America Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
Figure 19. North America Pulmonary Embolism Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pulmonary Embolism Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 23. Europe Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
Figure 24. Europe Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
Figure 25. Europe Pulmonary Embolism Therapeutics Market Share by Country (2019-2030)
Figure 26. Germany Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. China Pulmonary Embolism Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 33. China Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
Figure 34. China Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
Figure 35. Asia Pulmonary Embolism Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 36. Asia Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
Figure 37. Asia Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
Figure 38. Asia Pulmonary Embolism Therapeutics Market Share by Region (2019-2030)
Figure 39. Japan Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. China Taiwan Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. India Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Australia Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
Figure 47. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
Figure 48. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Share by Country (2019-2030)
Figure 49. Brazil Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Mexico Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Turkey Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Israel Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. GCC Countries Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Boehringer Ingelheim International Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2019-2024)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2019-2024)
Figure 57. Daiichi Sankyo Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2019-2024)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2019-2024)
Figure 59. Johnson & Johnson Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral
Table 4. Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Pulmonary Embolism Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pulmonary Embolism Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Pulmonary Embolism Therapeutics Market Share by Region (2019-2024)
Table 8. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Pulmonary Embolism Therapeutics Market Share by Region (2025-2030)
Table 10. Pulmonary Embolism Therapeutics Market Trends
Table 11. Pulmonary Embolism Therapeutics Market Drivers
Table 12. Pulmonary Embolism Therapeutics Market Challenges
Table 13. Pulmonary Embolism Therapeutics Market Restraints
Table 14. Global Pulmonary Embolism Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Pulmonary Embolism Therapeutics Revenue Share by Players (2019-2024)
Table 16. Global Top Pulmonary Embolism Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Embolism Therapeutics as of 2023)
Table 17. Global Pulmonary Embolism Therapeutics Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Pulmonary Embolism Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Pulmonary Embolism Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Pulmonary Embolism Therapeutics, Product and Application
Table 21. Global Key Players of Pulmonary Embolism Therapeutics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Pulmonary Embolism Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Pulmonary Embolism Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Pulmonary Embolism Therapeutics Revenue Share by Application (2019-2024)
Table 29. Global Pulmonary Embolism Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Pulmonary Embolism Therapeutics Revenue Share by Application (2025-2030)
Table 31. North America Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Pulmonary Embolism Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Pulmonary Embolism Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Pulmonary Embolism Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Pulmonary Embolism Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Pulmonary Embolism Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Pulmonary Embolism Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Pulmonary Embolism Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Pulmonary Embolism Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Pulmonary Embolism Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Pulmonary Embolism Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Pulmonary Embolism Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Pulmonary Embolism Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Pulmonary Embolism Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Pulmonary Embolism Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Pulmonary Embolism Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Pulmonary Embolism Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Pulmonary Embolism Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 63. Boehringer Ingelheim International Company Details
Table 64. Boehringer Ingelheim International Business Overview
Table 65. Boehringer Ingelheim International Pulmonary Embolism Therapeutics Product
Table 66. Boehringer Ingelheim International Revenue in Pulmonary Embolism Therapeutics Business (2019-2024) & (US$ Million)
Table 67. Boehringer Ingelheim International Recent Developments
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Pulmonary Embolism Therapeutics Product
Table 71. Bristol-Myers Squibb Revenue in Pulmonary Embolism Therapeutics Business (2019-2024) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Developments
Table 73. Daiichi Sankyo Company Details
Table 74. Daiichi Sankyo Business Overview
Table 75. Daiichi Sankyo Pulmonary Embolism Therapeutics Product
Table 76. Daiichi Sankyo Revenue in Pulmonary Embolism Therapeutics Business (2019-2024) & (US$ Million)
Table 77. Daiichi Sankyo Recent Developments
Table 78. F. Hoffmann-La Roche Company Details
Table 79. F. Hoffmann-La Roche Business Overview
Table 80. F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Product
Table 81. F. Hoffmann-La Roche Revenue in Pulmonary Embolism Therapeutics Business (2019-2024) & (US$ Million)
Table 82. F. Hoffmann-La Roche Recent Developments
Table 83. Johnson & Johnson Company Details
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Pulmonary Embolism Therapeutics Product
Table 86. Johnson & Johnson Revenue in Pulmonary Embolism Therapeutics Business (2019-2024) & (US$ Million)
Table 87. Johnson & Johnson Recent Developments
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Pulmonary Embolism Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. Parenteral Features
Figure 5. Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Pulmonary Embolism Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. Adult Case Studies
Figure 8. Child Case Studies
Figure 9. Pulmonary Embolism Therapeutics Report Years Considered
Figure 10. Global Pulmonary Embolism Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Pulmonary Embolism Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pulmonary Embolism Therapeutics Market Share by Region: 2023 VS 2030
Figure 13. Global Pulmonary Embolism Therapeutics Market Share by Players in 2023
Figure 14. Global Top Pulmonary Embolism Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Embolism Therapeutics as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Pulmonary Embolism Therapeutics Revenue in 2023
Figure 16. North America Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
Figure 18. North America Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
Figure 19. North America Pulmonary Embolism Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pulmonary Embolism Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 23. Europe Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
Figure 24. Europe Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
Figure 25. Europe Pulmonary Embolism Therapeutics Market Share by Country (2019-2030)
Figure 26. Germany Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. China Pulmonary Embolism Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 33. China Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
Figure 34. China Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
Figure 35. Asia Pulmonary Embolism Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 36. Asia Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
Figure 37. Asia Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
Figure 38. Asia Pulmonary Embolism Therapeutics Market Share by Region (2019-2030)
Figure 39. Japan Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. China Taiwan Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. India Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Australia Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Share by Type (2019-2030)
Figure 47. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Share by Application (2019-2030)
Figure 48. Middle East, Africa, and Latin America Pulmonary Embolism Therapeutics Market Share by Country (2019-2030)
Figure 49. Brazil Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Mexico Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Turkey Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Israel Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. GCC Countries Pulmonary Embolism Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Boehringer Ingelheim International Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2019-2024)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2019-2024)
Figure 57. Daiichi Sankyo Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2019-2024)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2019-2024)
Figure 59. Johnson & Johnson Revenue Growth Rate in Pulmonary Embolism Therapeutics Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232